You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 亞太藥業接近跌停 全年預計虧損6.5億至7.5億元 料將計提商譽減值
格隆匯 10-30 11:55
格隆匯10月30日丨亞太藥業(002370.SZ)接近跌停,報7.07元,成交1.67億元,總市值38億元。據公司昨晚發佈的三季報顯示,前三季度實現營業收入7.25億元,同比下降24.37%;實現歸屬於上市公司股東的淨利潤690.86萬元,同比下降95.85%。在第三季度,公司營業收入為1.51億元,同比下降49.10%;歸屬於上市公司股東的淨利潤為虧損3333.05萬元,同比下降194.63%。亞太藥業前三季度的業績不理想還在投資者預期之中。畢竟此前公司已經發布業績預告,預計前三季度淨利潤為0至1665.71萬元,同比下降90%~100%。更讓投資者擔憂的是,亞太藥業全年業績可能大幅下滑。在三季報中,上市公司預計,全年淨利潤虧損6.5億~7.5億元。而在2018年度,公司歸屬於上市公司股東的淨利潤為2.08億元。今年業績可能出現巨大變化的原因是計提商譽減值。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account